BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)
$7.76 0.3 (4.0214%)
Analysed BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) News Sources
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
24-04-2026
biopharmadive.com
Here Are Monday’s Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy’s, and More
11-05-2026
247wallst.com
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
12-05-2026
yahoo.com
BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress
12-05-2026
yahoo.com
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
15-05-2026
fool.com
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
15-05-2026
fool.com
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
15-05-2026
fool.com
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More
17-05-2026
fool.com
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
17-05-2026
fool.com
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
17-05-2026
fool.com
What is the current price of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)?
The current price of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) is $7.76.
BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) absolute price change since previous trading day?
The absolute price change of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) since the previous trading day is $0.3.
BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) percentage price change since previous trading day?
The percentage price change of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) since the previous trading day is 4.0214%.
What is the most recent average sentiment score for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)?
The most recent average sentiment score for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)?
The most recent sentiment for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) is .
SEC-8K** Filing Available For BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.